for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

Went down 20% but now recovering.

Probably just MM's playing games ..

... before the big push to 50p

lol

Nothing ...ZZZZZZZZZZZzzzzzzzzzzzzz

20P BY NEXT YEAR...HMMM 40 BAGGER WILL DO ME

just a waiting game

MY ITS QUIET ON HERE NOWDAYS

life in the old dog yet!!

Could do with a bowl of Winalot though!

Well there was a suprise.

Have to wait for Dil to knock this:-

Stanelco sales up 12% for first nine months
Business Financial Newswire
Stanelco reports revenue grew strongly during the nine months to 30 September and overall trading was in line with management expectations.

The engineering group's sales to 30 September were up 12% at 13.4m. It says it continues to be confident in the outlook for the full year.

The group saw a 29% increase in direct bioplastic sales, a 30% increase in the Radio Frequency Applications division and an 8% increase in third-party sales from the Biotec joint venture.

Stanelco's cash position was 3.7m, strengthened since the half-year by working capital improvements including a reduction in stock levels following the summer production holiday.

Bioplastics has added more than 40 new customers in 2009 and widened the set of end-use applications by a further 17.

The RF Applications order pipeline continues to strengthen with a particular emphasis on India and China. A new sales consultant has been appointed for the Indian market.

now i wonder why there is no mention of profits .... for rocket scientists and baboons only!

Baboon,

Some more information for you!
================
RNS Number : 0801C
Stanelco PLC
06 November 2009




6 November 2009


Stanelco plc ("the Company" or "the Group")


Interim Management Statement


Stanelco plc issues its interim management statement for the period from 1 January 2009 to 5 November 2009, as required by the UK Listing Authority's Disclosure and Transparency Rules.


Highlights


*

Sales to 30 September up 12% to 13.4m
*

Trading performance in line with Board's expectations:
*

Continued growth in bioplastics division driven by interest in adopting sustainable products; increasing applications in new sectors
*

Radio frequency applications division sales order pipeline continued to strengthen; growing overseas sales in China and India

*

Closing cash position at 30 September 3.7m, increased by working capital improvements
*

Board confident in full year outlook


Trading Update



Group revenues grew strongly during the nine months to 30 September 2009 and the Group's overall trading performance was in line with the Board's expectations.


Group revenues increased from 12.0m to 13.4m in the nine months to 30 September 2009, an increase of 12% compared with the same period last year. This reflected a 29% increase in bioplastic sales made directly by the Company, a 30% increase in sales in RF Applications division and an 8% increase in third party sales from our joint venture, Biotec.


Our cash position at 30 September 2009 was 3.7m, strengthened since the half year by working capital improvements, including a reduction in stock levels following the summer production holiday.


Bioplastics division


In the Bioplastics division, the sales team that was established last year has had a number of successes in growing sales of the Group's existing biodegradable products into the market, delivering a 29% increase in the Company's bioplastic sales in the nine months to 30 September 2009. The division has broadened its customer base with over 40 new customers in 2009 and widened the set of end-use applications by a further 17 in the same period. The management remain encouraged by the division's opportunities for growth.


The product development team continues to work closely with a number of blue chip customers and mainstream plastics convertors to develop a widening range of biodegradable products that can substitute oil-based plastics. Whilst some of these development paths are still at an early stage, others are poised to deliver further growth in the coming months. The development team continues to focus on those accounts which we consider could have the maximum growth potential.


We continue to see strong demand for bioplastic products in the market, driven not only by concerns about waste disposal but also by the desire of many large corporations to switch to using sustainable resources in key brands. This switch to the use of "renewable" materials in advance of legislation is seen as both a branding enhancement and a hedge against further oil based price rises. Sectors in which we are gaining traction include packaging, waste disposal, paper products, personal care, horticulture and electronics. The sales development work undertaken in the USA over the past year is now also gaining momentum.


Our joint venture, Biotec, delivered 8% growth in its third party sales for the 9 months to 30 September 2009 compared with the same period last year.


Radio Frequency (RF) applications division


In the RF Applications division, the team has been fulfilling a number of significant orders that have been won in the nine months to 30 September 2009, including the 0.3m order for RF furnaces disclosed in our interim results. Sales in the period increased by 30% compared with the same period last year including growth in both optical fibre furnaces and more general industrial equipment in which we are building a portfolio of customers making repeat orders. The sales order pipeline continues to strengthen with a particular emphasis on sales in India and China. As a result, a new sales consultant has now been appointed for Stanelco dedicated to the Indian market, as this territory shows signs of increasing growth in the next few years.



Outlook


The Board continues to be confident in the outlook for the full year. Our focus continues to be on working closely with customers with the potential to deliver increases in revenue, whilst considering acquisition opportunities and other paths that could significantly increase the scale of the business and deliver shareholder value.



- Ends -


For further information please contact:


Paul Mines, Chief Executive, Stanelco plc

Sue Bygrave, Group Finance Director, Stanelco plc




Tel: +44 (0) 2380 867100


Jonathon Brill/Caroline Stewart,

Financial Dynamics


Tel: +44 (0) 20 7831 3113

what's the diff between turnover and the big P word? ....... clearly no one on this BB knows, nor the board of SEO!!

be thankful it's not dead in the water...at least we baboons have a chance....god knows when of getting a bit of cash back. At least they appear to be trying, cheers fred, and raspberry to cynic...:))

baboons have a chance of what? ..... chewing their nuts?

If they avoid chewing our nuts that will be a bonus!

where did you get yours from?

Tescos!

buy one, get one free?

Better than that - reduced cos at sell by date!

sounds like me!